97921045 - UPTEMPO

Information

• Trademark
• 97921045

• Source

• Serial Number

  97921045

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 04, 2023
  a year ago

• Transaction Date

  September 27, 2024
  3 months ago

• Status Date

  September 27, 2024
  3 months ago

• Published for Opposition Date

  January 23, 2024
  11 months ago

• Location Date

  May 14, 2024
  7 months ago

• Status Code

  730

• Current Location

  INTENT TO USE SECTION

  Employee Name

  EINSTEIN, MATTHEW

• Attorney Docket Number

  20332.1019

  Attorney Name

  Vanessa A. Ignacio, Esq.

  Law Office Assigned Location Code

  M60

• Owners

  • CATALENT PHARMA SOLUTIONS, INC

Case File Statements

• GS0401: Custom manufacture of cells and cell lines for use in viral vector production, and for diagnostic, medical and commercial applications in relation to cell and gene therapies
• GS0051: Cells and cell lines for medical or clinical use; Stem cells for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, DNA plasmids, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use; Pharmaceutical preparations in the nature of viral systems, gene therapy systems, and nucleic acid delivery systems comprised of viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells used to deliver modified genetic material into other cells for medical purposes
• GS0011: Cells and cell lines for scientific, laboratory or medical research; Reagents for scientific or medical research use; Biological and biochemical preparations, namely, plasmids, RNA and proteins for scientific, medical research, or research use; Cell culture reagents for scientific and research use; Stem cells for research or scientific purposes; Biological preparations for use in cell cultures other than for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for use in scientific research and analysis
• GS0421: Pharmaceutical research and development; Gene therapy research; Cell therapy research; Scientific research

Case File Event Statements

• 5/8/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/4/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/20/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/21/2023 - a year ago

  4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/3/2024 - a year ago

  5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/23/2024 - 11 months ago

  6 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/23/2024 - 11 months ago

  7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 2/13/2024 - 10 months ago

  8 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 4/3/2024 - 9 months ago

  9 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP

• 5/14/2024 - 7 months ago

  10 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 9/27/2024 - 3 months ago

  11 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 9/27/2024 - 3 months ago

  14 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 9/27/2024 - 3 months ago

  13 - SOU EXTENSION 1 GRANTED Type: EX1G

• 9/27/2024 - 3 months ago

  12 - SOU EXTENSION 1 FILED Type: EXT1